Humanized cobra venom factor decreases myocardial ischemia-reperfusion injury (Q42132835)

17 October 2017

Humanized cobra venom factor decreases myocardial ischemia-reperfusion injury (English)

1 reference

17 October 2017

0 references

1 reference

W Brian Gorsuch

1

1 reference

17 October 2017

Benjamin J Guikema

2

1 reference

17 October 2017

David C Fritzinger

3

1 reference

17 October 2017

Carl-Wilhelm Vogel

4

1 reference

17 October 2017

Gregory L Stahl

5

1 reference

17 October 2017

10 September 2009

1 reference

17 October 2017

1 reference

17 October 2017

47

1 reference

17 October 2017

2-3

1 reference

17 October 2017

506-510

1 reference

Derivatives of human complement component C3 for therapeutic complement depletion: a novel class of therapeutic agents

17 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Mannose-binding lectin plays a critical role in myocardial ischaemia and reperfusion injury in a mouse model of diabetes

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletion

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Role for the alternative complement pathway in ischemia/reperfusion injury

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Complement. Second of two parts

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Complement. First of two parts

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Complement localization and mediation of ischemic injury in baboon myocardium

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Cobra venom factor: improved method for purification and biochemical characterization.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Reduction by Cobra Venom Factor of Myocardial Necrosis after Coronary Artery Occlusion

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Long-Term Preservation of Ischemic Myocardium after Experimental Coronary Artery Occlusion

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

N-linked oligosaccharides of cobra venom factor contain novel alpha(1-3)galactosylated Le(x) structures

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Immunoreactivity and function of oligosaccharides in cobra venom factor.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Concerning the mechanism of pexelizumab's benefit in acute myocardial infarction

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2787894

Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion

1 December 2018

1 reference

12 December 2020

Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury

1 reference

12 December 2020

Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial)

1 reference

12 December 2020

Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury

1 reference

12 December 2020

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

1 reference

12 December 2020

10.1016/J.MOLIMM.2009.08.017

Identifiers

DOI

1 reference

17 October 2017

1 reference

17 October 2017

1 reference